检索结果-南通市图书馆

Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma

在线全文

学校读者我要写书评

暂无评论

hepatobiliary & Pancreatic Diseases International 2002年第4期1卷 523-526页

作者： Yun-Quan Luo Yi Wang Han Chen meng-chao wu the eastern hepatobiliary surgery hospital, second military medical university, shanghai 200438, china eastern hepatobiliary surgery Hosp. Second Military University Shanghai 200438 China

Objective: To assess the influence of preoperative transcatheter arterial chemoembolization (TACE) on liver resection in patients with resectable hepato- cellular carcinoma (HCC). Methods: Of 126 patients with resectable HCC, 62 received preoperative TACE (TACE group) and the remaining 64 patients were selected as controls (non- TACE group). Perioperative risk factors including liver function alteration, mean blood loss during op- eration, mean time of clamping the porta hepatis, length of operation, postoperative abdominal drain- age at day 1, 2 and 3, morbidity and mortality were compared between the two groups. Results: Neither significant difference in liver func- tion alteration nor mortality was observed between the two groups. More severe hepatic cirrhosis, lon- ger operation time, more blood loss and postopera- tive abdominal drainage were noted in the TACE group than in the non-TACE group. There was no significant difference in postoperative morbidity be- tween the two groups. Conclusions: Preoperative TACE for resectable HCC increases surgical difficulty and risk, and therefore should be considered prudently according to the indi- viduality of patients.

关键词： hepatocellular carcinoma therapeutic chemoembolization hepatectomy

E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma

在线全文

学校读者我要写书评

暂无评论

hepatobiliary & Pancreatic Diseases International 2002年第1期1卷 80-82页

作者： Bao-Hua Zhang Han Chen Xiao-Ping Yao Wen-Ming Cong meng-chao wu From the eastern hepatobiliary surgery hospital, second military medical university of PLA, shanghai 200438, china eastern hepatobiliary Surg. hospital Second Military Medical Univ. of PLA Shanghai 200438 China

Objective: To study the significance of E-selectin andits ligand-sLeX in the metastasis of hepatocellularcarcinoma (HCC).Methods: Flow cytometry and immunohistochemistrywere used to detect the expression of E-selectin and itsligand-sLeX in both HCC cell lines and human ***: The positive rate of E-selectin in vascular en-dothelial cells adjacent to cancer was 67.9% (19/28). Theexpression of E-selectin in tumors accompanied withemboli or satellite foci was significantly higher than thatin tumors without emboli or satellite foci (P<0.05),and it was not related to tumor size, tumor capsule,AFP content, and the degree of differentiation. Thepositive expression of sLeX in SMMU-7721, PLF/PRF/5 and HepGⅡ cell lines was 7.03%, 63.35% and97.29% respectively. The positive cells of sLeX mainlydistributed in the margin of tumor tissues. The positiveexpression of sLeX in HCC cells in emboli or invasivetumor tissues was much higher than in primary ***: E-selectin and its ligand-sLeX are closelycorrelated with the metastasis of HCC.

关键词： liver neoplasm E-selectin sLeX metastasis

Effect of Sirpα1 on the expression of nuclear factor-kappa B in hepatocellular carcinoma

在线全文

学校读者我要写书评

暂无评论

hepatobiliary & Pancreatic Diseases International 2007年第3期6卷 276-283页

作者： Jian-Min Qin,Xing-Wang Wan,Jin-Zhang Zeng and meng-chao wu Department of hepatobiliary and Pancreatic surgery,Beijing chaoyang hospital,Capital university of medical Sciences,Beijing 100020,china and eastern hepatobiliary surgery hospital,second military medical university,shanghai 200438, china Department of hepatobiliary and Pancreatic surgery Beijing Chaoyang Hospital Capital University of Medical Sciences Beijing 100020 China. jianminqin@***

BACKGROUND:Signal regulatory protein alpha1(Sirpα1) is a member of Sirps families containing four immunoreceptor tyrosine-based inhibitory motifs(ITIMs) domains in the cytoplasm of and an activated substrate of receptor tyrosine kinase(RTK),that negatively regulates the RTK-dependent cell proliferating signal transduction *** we found that Sirpα1 was closely associated with the occurrence and development of hepatocellular carcinoma(HCC)as well as liver *** it is unclear about the regulatory mechanisms,we established the cell line transfected Sirpα1 gene and preliminarily clarified the mechanisms by which Sirpα1 negatively regulates the carcinogenesis and development of HCC. METHODS:Liver cancer Sk-Hep1 cell was respectively transfected with plasmids of pLXSN,pLXSN-Sirpα1 and pLXSN-Sirpα1Δ4Y 2 ,screened with the drug of G418(1200 μg/ml),and various transfected Sk-Hep1 cell lines were *** protein expressions of P65,P50,IκBα,cyclin D1 and Fas in various Sk-Hep1 cell lines were determined by Western blotting,and P65 and P50 were localized by the immunofluorescence technique. RESULTS:Sirpα1 could significantly upregulate the protein expression of IκBα(*** cell lines,P<0.05) in the Sk-Hep1 cell,and downregulate the protein expressions of P65,P50 and cyclin D1(*** cell lines, P<0.05)in the Sk-Hep1 cell.P65 protein expression was mainly localized in the cytoplasm in the pLXSN Sk-Hep1 cell,and in the nucleus of the Sk-Hep1 cell with mutantSirpα1Δ4Y 2 ,but in nucleus of the Sk-Hep1 cell with wild Sirpα1.P50 protein expression was localized in the cytoplasm and nucleus of the pLXSN Sk-Hep1 cell,but in the nucleus of the Sk-Hep1 cell with wild Sirpα1 and mutant Sirpα1Δ4Y 2 plasmid. CONCLUSIONS:Sirpα1 might negatively regulate and control the abnormal proliferation of liver cancer cells by influencing the protein content and localization of nuclear factor-kappa B,then influence the expression of cyclins such as cyclin D1 in the si

关键词： signal regulatory protein alpha1 carcinoma,hepatocellular nuclear transcription factor

Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis

在线全文

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2012年第4期18卷 349-355页

作者： Qian Zhang,Department of Infectious Diseases,Changhai hospital,second military medical university,shanghai 200433,china Zhi-Qing Li,Hu Liu,Jia-He Yang,Department of Hepatic surgery,eastern hepatobiliary surgery hospital,second military medical university,shanghai 200438,china Qian Zhang Department of Infectious Diseases Changhai Hospital Second Military Medical University Shanghai 200433 China.

AIM:To investigate the inhibitory effect of hepatitis B virus (HBV) preS2 antibody (preS2Ab) against HBV in-fection and HBV-associated hepatic ***:An adenoviral vector carrying the full-length light and heavy chains of the HBV preS2Ab gene,Ad315-preS2Ab,was *** linked immunosorbent assay (ELISA) and Western blotting analyses were used to determine the preS2Ab expres-sion levels in *** techniques were used to examine the binding affinity between the expressed HBV preS2Ab and HBV-positive liver *** were also used to determine hepatitis B surface antigen (HBsAg) levels to assess the inhibitory effect of the preS2Ab against HBV infection in L02 *** inhibitory effect of preS2Ab against hepatic carcinogen-esis was studied with diethylnitrosamine (DEN)-induced hepatocellular carcinomas (HCCs) in HBV transgenic ***:The expression of HBV preS2Ab increased with increases in the multiplicity of infection (MOI) of Ad315-preS2Ab in L02 cells,with 350.87 ± 17.37 μg/L of preS2Ab when the MOI was 100 plaque forming units (pfu)/*** expressed preS2Abs could recog-nize liver cells from HBV transgenic *** results showed that L02 cells expressing preS2Ab produced less HBsAg after treatment with the serum of HBV pa-tients than parental L02 cells expressing no *** transgenic mice treated with Ad315-preS2Ab had fewer and smaller cancerous nodes after induction with DEN than mice treated with a blank Ad315 vec-tor or untreated ***,the administration of Ad315-preS2Ab could alleviate hepatic cirrhosis and decrease the serum levels of alanine transaminase and aspartate ***:Adenovirus-mediated HBV preS2Ab expression could inhibit HBV infection in L02 cells,and then inhibit DEN-induced hepatocellular carcinogenesis and protect hepatic function in HBV transgenic mice.

关键词： Hepatitis B virus Adenoviral vector PreS2 antibody Hepatocellular carcinoma Gene therapy

Clinical and Experimental Research of Primary Liver Cancer in china

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

The Chinese-German Journal of Clinical Oncology 2002年第1期1卷 1-4页

作者： wu mengchao Eastem hepatobiliary surgery hospital, second military medical university, shanghai 200438, china eastern hepatobiliary surgery hospital Second Military Medical University Shanghai China

Primary liver cancer (PLC) is one of the most common neoplasms and the second cancer-related cause of death in china, respresenting a major health problem. In china, PLC resulted in 20.40 deaths per lO0 000 per year,with 19.98 per 100 000 in cities and 23.59 per 100 000 inrural areas. Of all the newly enrolled PLC cases in the world each year, about 43% are found in the mainland of china.

关键词：肝癌 PLC 中国死亡率手术治疗器官移植

Resection of the Caudate Lobe Tumor of Liver

在线全文

学校读者我要写书评

暂无评论

The Chinese-German Journal of Clinical Oncology 2002年第1期1卷 19-20页

作者： ZHOU Weiping, wu mengchao, YAO Xiaoping eastern hepatobiliary surgery hospital, second military medical university, shanghai 200438, china eastern hepatobiliary surgery hospital Second Military Medical University Shanghai China

Objective To analyze the operative technique and results of the resection for caudate lobe carcinoma of the liver. Methods The liver was fully freed of the ligments, short hepatic veins were divided and sutured, and the tumor was then freed from the inferior vena cava(IVC) . The caudate lobe was resected alone or in combination with other segment.Results 28 patients underwent resection of caudate lobe tumor. The number of the short hepatic veins transected and tied was 2-5 ( mean 3) . An intermittent Pringle' s manoeuver was used in 26 patients with a median occlusion time of 21.7 ( range 10-32) min. The median blood loss was 574 (range 100? 300) ml. No major complications such as massive bleeding and biliary fistula occurred. Intraop-erative total vascular occlusion was perfored on only 5 cases. All patients were discharged from the hospital. Outpatient periodic TAE plus chemotherapy was performed. Postoperative recurrence and metastasis was found in 13 cases,with 5 deaths.Conclusion The use of third porta hepatis dissection for resection of the caudate lobe tumor can reduce the risk of massive bleeding during the operation and can raise the rate of resection of caudate lobe tumor.

关键词： liver neoplasms hepatectomy

Post-Surgical Recurrence of Hepatocellular Carcinoma

在线全文

学校读者我要写书评

暂无评论

The Chinese-German Journal of Clinical Oncology 2002年第1期1卷 30-31页

作者： CHENG Hongyan Department of Radiology, eastern hepatobiliary surgery hospital, second military medical university, shanghai 200438, china Department of Radiology Eastem Hepatobiliary Surgery Hospital Second Military Medical University Shanghai China

Objective To analyze post-surgical recurrence of hepatocellular carcinoma (HHC) according to pathologic findings, primary tumor and angiographic features of the recurrent tumor.Methods In this series, 100 cases of recurrent HCC were analyzed in following aspects: ( 1) size, tumor nodular numbers, gross and histologic findings of the primary tumor; (2) post-surgical recurrent time; (3) size, tumor nodular numbers, blood supply, staining property, and accumulation of lipiodol oil in the recurrent tumor. Following angiography, arterial chemoembolization was performed. Results In the primary tumor, single nodules were seen in 80 cases, multiple nodules in 16 cases and multiple fused nodules in 4 cases. All tumors were classified as: trabecular type, 65 cases; compact type, 12; sclerotic type, 2 cases; mixed type, 15 cases and cholangiocarcinoma type, 6 cases. 38 cases had incomplete or no capsule. Satellite tumor nodules were grossly identified during operation in 33 cases, but were proven microscopically in 66 cases. Tumor thrombi of portal vein was noted in 18 cases during oeration, but 85 cases in histopathological sections. The recurrent tumors were diagnosed post surgically within 6 months in 67 cases, 6-12 months in 15 cases and after 12 months in 18 cases respectively. On angiography, 67 % recurrent tumors was rich in blood supply and with abundant accumulation of lipiodol after embolization.Conclusion The post-surgical recurrence rate of the HCC patients with massive size, incomplete or no capsule, satellite tumor nodules and portal vein tumor thrombus was high. The patients shoud receive angiography in 1 ?2 months after surgery in order to detect early recurrence and, if confirmed, the patients may be treated by transcatheter arterial chemoembolization

关键词： hepatocellular carcinoma recurrence

Combined invagination and duct-to-mucosa techniques with modifications:anew method of pancreaticojejunal anastomosis

在线全文

学校读者我要写书评

暂无评论

hepatobiliary & Pancreatic Diseases International 2011年第4期10卷 422-427页

作者： Bin Zhu,Li Geng,You-Gang Ma,Yong-Jie Zhang and meng-chao wu second Department of Biliary surgery and Department of Special Treatment,eastern hepatobiliary surgery hospital,second military medical university,shanghai 200438,china second Department of Biliary surgery Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai 200438 China Department of Special Treatment Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai 200438 China

BACKGROUND:Soft pancreatic texture and a small main pancreatic duct are thought to be the most significant risk factors for the occurrence of pancreatic fistula (PF),a common and serious complication after pancreaticoduodenectomy (PD).This is in part due to the technical difficulties of pancreaticojejunostomy (PJ) posed by a soft gland with a normal-sized *** deal with this problem,we developed a new anastomotic technique which combines the two most widely used techniques,namely,the invagination technique and the duct-to-mucosa technique,with a modification of the suture route and insertion of a temporary stent ***:Between January 2003 and December 2009,ninetytwo consecutive patients underwent PD in which the new PJ technique was *** and follow-up data of these patients were reviewed for operative details,early postoperative events,and outcomes at 6 months after the *** was defined by the International Study Group on Pancreatic Fistula (ISGPF) guidelines and graded (A,B or C) according to the clinical procedures and ***:In this group of 92 patients,there was only 1 early death from acute renal *** was observed in 11 patients (12.0%),8 in grade A,1 in grade B,and 2 in grade *** the 2 patients in grade C,PF was surgically *** were no early or late deaths attributable to *** months after the operation,all of the patients were free of PJ-related symptoms except for 2,who were found to have ***:Our modified technique is simple and safe in *** data suggest that this technique produces excellent early and medium-term results.

关键词： pancreaticoduodenectomy pancreaticojejunostomy pancreatic fistula

From cell signaling to cancer therapy

在线全文

学校读者我要写书评

暂无评论

Acta Pharmacologica Sinica 2007年第9期28卷 1494-1498页

作者： Jin DING Yun FENG Hong-yang WANG The International Cooperation Laboratory on Signal Transduction,eastern hepatobiliary surgery Institute,second military medical university,shanghai 200438,china TheInternationalCooperationLaboratoryonSignalTransduction EasternHepatobiliarySurgeryInstituteSecondMilitary.MedicalUniversityShanghai200438China

Cancer has been seriously threatening the health and life of humans for a *** the intensive effort put into revealing the underlying mechanismsof cancer,the detailled machinery of carcinogenesis is still far from fully *** studies have illustrated that cell signaling is extensively involved intumor initiation,promotion and ***,targeting the key mol-ecules in the oncogenic signaling pathway might be one of the most promisingways to conquer *** targeted drugs,such as imatinib mesylate (Gleevec),herceptin,gefitinib (Iressa),sorafenib (Nexavar) and sunitinib (Sutent),whichevolve from monotarget drug into multitarget ones,have been developed withencouraging effects.

关键词： cell signaling cancer therapy chemotherapy